Titre : Empyème pleural

Empyème pleural : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Empyème pleural : Questions médicales les plus fréquentes", "headline": "Empyème pleural : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Empyème pleural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-25", "dateModified": "2025-04-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Empyème pleural" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Empyème", "url": "https://questionsmedicales.fr/mesh/D004653", "about": { "@type": "MedicalCondition", "name": "Empyème", "code": { "@type": "MedicalCode", "code": "D004653", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.470.756.305" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Empyème tuberculeux", "alternateName": "Empyema, Tuberculous", "url": "https://questionsmedicales.fr/mesh/D004654", "about": { "@type": "MedicalCondition", "name": "Empyème tuberculeux", "code": { "@type": "MedicalCode", "code": "D004654", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.470.756.305.250.320" } } } ], "about": { "@type": "MedicalCondition", "name": "Empyème pleural", "alternateName": "Empyema, Pleural", "code": { "@type": "MedicalCode", "code": "D016724", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Cheng-Li Lin", "url": "https://questionsmedicales.fr/author/Cheng-Li%20Lin", "affiliation": { "@type": "Organization", "name": "Management Office for Health Data, China Medical University Hospital , Taichung, Taiwan." } }, { "@type": "Person", "name": "Te-Chun Shen", "url": "https://questionsmedicales.fr/author/Te-Chun%20Shen", "affiliation": { "@type": "Organization", "name": "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, No. 2, Yude Road, Taichung, 404, Taiwan." } }, { "@type": "Person", "name": "Danail B Petrov", "url": "https://questionsmedicales.fr/author/Danail%20B%20Petrov", "affiliation": { "@type": "Organization", "name": "Medical University - Sofia, Sofia, Bulgaria." } }, { "@type": "Person", "name": "Dragan Subotic", "url": "https://questionsmedicales.fr/author/Dragan%20Subotic", "affiliation": { "@type": "Organization", "name": "University Hospital Basel, Basel, Switzerland." } }, { "@type": "Person", "name": "Georgi S Yankov", "url": "https://questionsmedicales.fr/author/Georgi%20S%20Yankov", "affiliation": { "@type": "Organization", "name": "Medical University - Sofia, Sofia, Bulgaria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Presence of HPV in prostate tissue from patients submitted to prostate biopsy.", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36651430", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/acb371205" } }, { "@type": "ScholarlyArticle", "name": "Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.", "datePublished": "2022-09-24", "url": "https://questionsmedicales.fr/article/36253300", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clgc.2022.09.007" } }, { "@type": "ScholarlyArticle", "name": "The mendelian randomized study revealed the association of prostatitis with prostate cancer risk.", "datePublished": "2024-10-20", "url": "https://questionsmedicales.fr/article/39428439", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-76355-4" } }, { "@type": "ScholarlyArticle", "name": "Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37271051", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmpb.2023.107624" } }, { "@type": "ScholarlyArticle", "name": "Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.", "datePublished": "2023-03-14", "url": "https://questionsmedicales.fr/article/36917412", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-023-03531-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Inflammation", "item": "https://questionsmedicales.fr/mesh/D007249" }, { "@type": "ListItem", "position": 5, "name": "Suppuration", "item": "https://questionsmedicales.fr/mesh/D013492" }, { "@type": "ListItem", "position": 6, "name": "Empyème", "item": "https://questionsmedicales.fr/mesh/D004653" }, { "@type": "ListItem", "position": 7, "name": "Empyème pleural", "item": "https://questionsmedicales.fr/mesh/D016724" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Empyème pleural - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Empyème pleural", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Empyème pleural", "description": "Comment diagnostique-t-on un empyème pleural ?\nQuels tests sont utilisés pour confirmer un empyème ?\nQuels signes cliniques indiquent un empyème ?\nL'imagerie est-elle toujours nécessaire ?\nPeut-on confondre un empyème avec une autre condition ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Empyème pleural", "description": "Quels sont les symptômes principaux d'un empyème ?\nL'empyème provoque-t-il des douleurs ?\nY a-t-il des symptômes systémiques associés ?\nLes symptômes varient-ils selon l'âge ?\nUn empyème peut-il être asymptomatique ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Empyème pleural", "description": "Comment prévenir un empyème pleural ?\nLes vaccinations aident-elles à prévenir l'empyème ?\nY a-t-il des mesures d'hygiène à respecter ?\nLes personnes âgées sont-elles plus à risque ?\nLe traitement des maladies chroniques aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Empyème pleural", "description": "Quel est le traitement principal de l'empyème ?\nDes antibiotiques sont-ils nécessaires ?\nQuand une intervention chirurgicale est-elle requise ?\nLe traitement est-il différent chez les enfants ?\nQuels soins de suivi sont nécessaires après traitement ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Empyème pleural", "description": "Quelles sont les complications possibles d'un empyème ?\nL'empyème peut-il entraîner des séquelles ?\nComment prévenir les complications ?\nLes complications sont-elles fréquentes ?\nQuelles sont les conséquences d'une septicémie liée à un empyème ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Empyème pleural", "description": "Quels sont les principaux facteurs de risque d'empyème ?\nLes antécédents médicaux influencent-ils le risque ?\nLe système immunitaire joue-t-il un rôle ?\nLes conditions de vie affectent-elles le risque ?\nLes maladies pulmonaires chroniques sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Prostatic+Neoplasms&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un empyème pleural ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (radiographie, échographie) et analyse du liquide pleural." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer un empyème ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une thoracocentèse permet d'analyser le liquide pleural pour confirmer l'infection." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un empyème ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, douleur thoracique, dyspnée et toux productive sont des signes fréquents." } }, { "@type": "Question", "name": "L'imagerie est-elle toujours nécessaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'imagerie est essentielle pour évaluer l'étendue de l'empyème et guider le traitement." } }, { "@type": "Question", "name": "Peut-on confondre un empyème avec une autre condition ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être confondu avec une pneumonie ou un abcès pulmonaire sans analyse précise." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux d'un empyème ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, douleur thoracique et essoufflement." } }, { "@type": "Question", "name": "L'empyème provoque-t-il des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur thoracique est fréquente, souvent aggravée par la respiration ou la toux." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme fatigue, malaise général et perte d'appétit peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent présenter des symptômes moins spécifiques que les adultes." } }, { "@type": "Question", "name": "Un empyème peut-il être asymptomatique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, un empyème peut être asymptomatique, surtout à ses débuts." } }, { "@type": "Question", "name": "Comment prévenir un empyème pleural ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par le traitement rapide des infections pulmonaires et des maladies sous-jacentes." } }, { "@type": "Question", "name": "Les vaccinations aident-elles à prévenir l'empyème ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations contre la pneumonie peuvent réduire le risque d'empyème." } }, { "@type": "Question", "name": "Y a-t-il des mesures d'hygiène à respecter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter le tabagisme peuvent aider à prévenir les infections." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru d'empyème en raison de leur santé générale." } }, { "@type": "Question", "name": "Le traitement des maladies chroniques aide-t-il ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle des maladies chroniques peut réduire le risque d'empyème." } }, { "@type": "Question", "name": "Quel est le traitement principal de l'empyème ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est le drainage du liquide pleural, souvent par thoracocentèse." } }, { "@type": "Question", "name": "Des antibiotiques sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antibiotiques sont prescrits pour traiter l'infection sous-jacente." } }, { "@type": "Question", "name": "Quand une intervention chirurgicale est-elle requise ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une intervention chirurgicale est nécessaire si le drainage ne suffit pas ou en cas de complications." } }, { "@type": "Question", "name": "Le traitement est-il différent chez les enfants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est similaire, mais les doses et les approches peuvent varier selon l'âge." } }, { "@type": "Question", "name": "Quels soins de suivi sont nécessaires après traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier est essentiel pour surveiller la guérison et prévenir les récidives." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'un empyème ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la fibrose pleurale, l'insuffisance respiratoire et la septicémie." } }, { "@type": "Question", "name": "L'empyème peut-il entraîner des séquelles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des séquelles comme des douleurs thoraciques chroniques ou des limitations respiratoires peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et approprié de l'empyème est essentiel pour prévenir les complications." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent survenir, surtout si l'empyème n'est pas traité rapidement." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une septicémie liée à un empyème ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La septicémie peut entraîner un choc septique, des défaillances d'organes et un risque de mortalité." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'empyème ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les infections pulmonaires, le tabagisme et les maladies chroniques augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de pneumonie ou de chirurgie thoracique augmentent le risque d'empyème." } }, { "@type": "Question", "name": "Le système immunitaire joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un système immunitaire affaibli augmente le risque d'infections et d'empyème." } }, { "@type": "Question", "name": "Les conditions de vie affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions de vie précaires ou surpeuplées peuvent augmenter le risque d'infections." } }, { "@type": "Question", "name": "Les maladies pulmonaires chroniques sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la BPCO augmentent le risque d'empyème en raison de l'inflammation." } } ] } ] }

Sources (10000 au total)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy.

Prostate cancer (PCa) is the second most frequent cancer among men in the Western population. Infections, such as the one caused by the human papillomavirus (HPV), have been shown to promote inflammat... Prostate tissue fragments were collected by prostate biopsy and subjected to polymerase chain reaction with primers for the HPV L1 gene to identify the presence of the virus.... Among 162 patients, 10 (6.2%) had HPV and in 152 (93.8%) HPV was not identified in prostate biopsies. HPV was detected in 7/95 (7.4%) of patients with PCa, in 2/55 (3.6%) of patients without PCa, and ... There were no significant levels of HPV L1 protein in prostate tissue. The findings suggest the absence of HPV oncogenic activity in the prostate tissue of patients with PCa....

Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals.

In this study, it was aimed to investigate the reliability of total prostate-specific antigen (t-PSA) in prostate cancer screening in hyperglycemic (≥126 mg/dL) individuals.... This research was planned as a cross-sectional retrospective study. Three hundred eleven cases which underwent biopsy with the suspicion of prostate cancer in the hospital were included in the study. ... It was determined that the t-PSA measurement was higher in the patient group with cancer (P < .001). It was determined that the median t-PSA levels of the intermediate and high cancer groups were high... As a contribution to literature, we found that the t-PSA test lost its sensitivity in cases with plasma glucose levels above normal. Loss of sensitivity may result in underdiagnosis in prostate cancer...

Automatic detection of prostate cancer grades and chronic prostatitis in biparametric MRI.

With emerging evidence to improve prostate cancer (PCa) screening, multiparametric magnetic prostate imaging is becoming an essential noninvasive component of the diagnostic routine. Computer-aided di... We collected 1647 fine-grained biopsy-confirmed findings, including Gleason scores and prostatitis, to form a training dataset. In our experimental framework for lesion detection, all models utilized ... An optimal model configuration with fine class granularity (prostatitis included) and OHE has scored the lesion-wise partial Free-Response Receiver Operating Characteristic (FROC) area under the curve... This paper examines several configurations for model training in the biparametric MRI setup and proposes optimal value ranges. It also shows that the fine-grained class configuration, including prosta...

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.

To assess the efficacy of 2-core prostate biopsy in advanced prostate cancer patients. This included a retrospective analysis of 12-core prostate biopsies and a prospective validation that a reduced n... The first phase analyzed retrospective data from 12-core prostate biopsies between January 2013 and 2018. In the second phase, from January 2018 to January 2022, in a prospective setting, patients wit... In the retrospective analysis, the number of positive cores in metastatic disease was 12 in 93 (73.8%), 11 in 14 (11.1%), and 10 in 7 (5.6%) patients. Using probability analysis, 94% of patients with ... A 2-core biopsy is adequate in almost all patients with metastatic prostate cancer with PSA > 75, and this avoids excess complications and morbidity associated with a systematic 12-core prostate biops...

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.

Financial toxicity (FT) is a growing concern among cancer survivors that adversely affects the quality of life and survival. Individuals diagnosed with aggressive cancers are often at a greater risk o... PCa patients enrolled in the North Carolina-Louisiana Prostate Cancer Project (PCaP) were recontacted for long-term follow-up. The prevalence of FT in the PCaP cohort was estimated. FT was estimated u... More than one-third of PCa patients reported experiencing FT. PCa aggressiveness was significantly independently associated with high FT; high aggressive PCa at diagnosis had more than twice the risk ... Aggressive PCa was associated with high FT. Future studies should collect more information about the characteristics of men with high FT and identify additional risk factors of FT....

Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

Cribriform (CBFM) pattern on prostate biopsy has been implicated as a predictor for high-risk features, potentially leading to adverse outcomes after definitive treatment. This study aims to investiga... Patients who underwent multiparametric magnetic resonance imaging (mpMRI), combined 12-core transrectal ultrasound (TRUS) guided systematic (SB) and MRI/US fusion-guided biopsy were retrospectively qu... Between 2015 and 2022, a total of 131 consecutive patients with CBFM pattern on prostate biopsy and pre-biopsy mpMRI were included. Clinical feature analysis included 1572 systematic biopsy cores (114... The extent of disease for CBFM-containing tumors is difficult to capture on mpMRI. When comparing MRI lesions of similar dimensions and PIRADS scores, CBFM-containing tumors appear to have larger canc...